<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FERMT2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>FERMT2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Fermitin Family Member 2</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Kindlin-2 (MITD2)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>14q22.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10979</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000173702</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9BUF5</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>614365</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">F0 domain</td>
<td>N-terminus</td>
</tr>
<tr>
<td class="label">F1 domain</td>
<td>Central</td>
</tr>
<tr>
<td class="label">F2 domain</td>
<td>Central</td>
</tr>
<tr>
<td class="label">F3 domain</td>
<td>C-terminus</td>
</tr>
<tr>
<td class="label">PH domain</td>
<td>C-terminus</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Rationale</td>
</tr>
<tr>
<td class="label">Integrin modulators</td>
<td>Modulate integrin-kindlin interaction</td>
</tr>
<tr>
<td class="label">Microglial targeting</td>
<td>Enhance Aβ clearance</td>
</tr>
<tr>
<td class="label">**BBB prot
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FERMT2 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>FERMT2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Fermitin Family Member 2</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Kindlin-2 (MITD2)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>14q22.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10979</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000173702</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9BUF5</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>614365</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">F0 domain</td>
<td>N-terminus</td>
</tr>
<tr>
<td class="label">F1 domain</td>
<td>Central</td>
</tr>
<tr>
<td class="label">F2 domain</td>
<td>Central</td>
</tr>
<tr>
<td class="label">F3 domain</td>
<td>C-terminus</td>
</tr>
<tr>
<td class="label">PH domain</td>
<td>C-terminus</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Rationale</td>
</tr>
<tr>
<td class="label">Integrin modulators</td>
<td>Modulate integrin-kindlin interaction</td>
</tr>
<tr>
<td class="label">Microglial targeting</td>
<td>Enhance Aβ clearance</td>
</tr>
<tr>
<td class="label">BBB protection</td>
<td>Maintain endothelial function</td>
</tr>
<tr>
<td class="label">Anti-inflammatory</td>
<td>Reduce neuroinflammation</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Basal ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>High</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Endothelial cells</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Integrins (β1, β3, β5)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Talin</td>
<td>Cooperative binding</td>
</tr>
<tr>
<td class="label">Vinculin</td>
<td>Focal adhesion</td>
</tr>
<tr>
<td class="label">Paxillin</td>
<td>Focal adhesion</td>
</tr>
<tr>
<td class="label">FAK</td>
<td>Signaling</td>
</tr>
<tr>
<td class="label">ILK</td>
<td>Signaling complex</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's disease</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">44 edges</a></td>
</tr>
</table>
FERMT2 (Fermitin Family Member 2), also known as Kindlin-2 or MITD2 (Mitogen-Induced Domain-2), encodes a member of the fermitin family of proteins. Kindlin-2 is a critical integrin-activating protein that plays essential roles in cell adhesion, focal adhesion formation, actin cytoskeleton organization, and cell migration. Genome-wide association studies (GWAS) have identified FERMT2 as a risk gene for late-onset Alzheimer's disease (LOAD), making it a protein of significant interest in neurodegeneration research[@lambert2013].
Kindlin-2 is a ~80 kDa protein containing several key domains:
Kindlin-2 is a key activator of integrin receptors through "inside-out" signaling:
Kindlin-2 and talin form a functional complex that fully activates integrins—neither alone is sufficient for maximal activation[@ushio2017].
Kindlin-2 is primarily localized to:
Kindlin-2 is essential for:
Through interactions with various partners:
Kindlin-2 regulates:
FERMT2 has emerged as a significant AD risk gene through GWAS[@kelley2018]:
GWAS Evidence:
While not a primary GWAS hit, FERMT2 may play roles:
FERMT2 is overexpressed in several cancers:
FERMT2 is expressed in multiple brain regions:
The following diagram shows the key molecular relationships involving FERMT2 Gene discovered through SciDEX knowledge graph analysis: